Centessa PharmaceuticalsCNTA
13F holders, Q1 2026 (March 31)161holders +14
48new positions
33sold out
6famous investors
$39.67avg. 13F price*
At the end of Q1 2026, 161 institutions reported holding Centessa Pharmaceuticals Ltd. (CNTA) in their 13F filings, up 14 from Q4 2025. 48 opened new positions and 33 sold out. The largest holders were Medicxi Ventures Management (Jersey) Ltd ($792.9M), Avoro Capital Advisors LLC ($454.0M) and Index Venture Life Associates VI Ltd ($395.7M). 6 famous investors held it, including Lee Ainslie (0.9% of Maverick Capital's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Centessa Pharmaceuticals Ltd.
- CUSIP
- 152309100
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 48 | $743.7M |
| Exits | 33 | $241.8M |
All 13F filers, Q4 2025 → Q1 2026: 39,615,498 shares bought and 34,740,722 shares sold, net +4,874,776 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 161 holders
| Medicxi Ventures Management (Jersey) Ltd | 80.76% | No change | 19,963,157 | $792.9M |
| Avoro Capital Advisors LLC | 4.47% | Reduce -21.5% | 11,430,455 | $454.0M |
| Index Venture Life Associates VI Ltd | 100.00% | No change | 9,961,789 | $395.7M |
| Adage Capital Partners Gp, L.L.C. | 0.55% | Reduce -20.9% | 8,925,010 | $354.5M |
| Pentwater Capital Management LP | 2.31% | New | 8,170,000 | $324.5M |
| FMR LLC | 0.01% | Reduce -23.5% | 6,852,047 | $272.2M |
| EcoR1 Capital, LLC | 10.19% | Add +92.6% | 6,000,000 | $238.3M |
| Perceptive Advisors LLC | 4.14% | Add +80.3% | 5,258,903 | $208.9M |
| Capital World Investors | 0.03% | Add +317.1% | 4,832,548 | $191.9M |
| Farallon Capital Management, L.L.C. | 1.14% | Reduce -10.6% | 4,809,000 | $191.0M |
| TCG Crossover Management, LLC | 4.87% | No change | 4,286,480 | $170.3M |
| Morgan Stanley | 0.01% | Add +284.9% | 4,268,353 | $169.5M |
| Paradigm Biocapital Advisors LP | 2.90% | New | 3,574,048 | $142.0M |
| Janus Henderson Group PLC | 0.07% | Reduce -14.7% | 3,492,977 | $138.7M |
| Deep Track Capital, LP | 2.59% | Add +57.9% | 3,158,041 | $125.4M |
| Logos Global Management LP | 4.35% | Add +962.5% | 2,125,000 | $84.4M |
| RTW Investments, LP | 0.81% | Add +14.7% | 2,054,175 | $81.6M |
| Federated Hermes, Inc. | 0.13% | Reduce -12.5% | 2,049,439 | $81.4M |
| Braidwell LP | 3.01% | Reduce -9.2% | 1,986,768 | $78.9M |
| Bank of America Corp. | 0.01% | Add +103.5% | 1,932,406 | $76.8M |
| Maverick Capital | 0.86% | Add +12.8% | 1,854,488 | $73.7M |
| First Light Asset Management, LLC | 5.56% | Reduce -31.5% | 1,560,991 | $62.0M |
| Affinity Asset Advisors, LLC | 3.33% | Add +133.1% | 1,400,000 | $55.6M |
| Foresite Capital Management VI LLC | 11.77% | No change | 1,364,019 | $54.2M |
| General Atlantic, L.P. | 2.50% | Reduce -77.8% | 1,354,830 | $53.8M |
| Goldman Sachs Group Inc. | 0.01% | Add +46.9% | 1,144,560 | $45.5M |
| Siren, L.L.C. | 1.16% | Reduce -73.8% | 1,053,464 | $41.8M |
| Cormorant Asset Management, LP | 2.10% | Reduce -20.8% | 1,050,000 | $41.7M |
| Alpine Associates Management Inc. | 2.03% | New | 865,500 | $34.4M |
| Woodline Partners LP | 0.13% | Add +48.6% | 859,105 | $34.1M |
| Balyasny Asset Management L.P. | 0.07% | Add +81.9% | 852,828 | $33.9M |
| Octagon Capital Advisors LP | 3.30% | No change | 750,000 | $29.8M |
| Millennium Management | 0.02% | Reduce -61.4% | 722,121 | $28.7M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.03% | New | 702,254 | $27.9M |
| American Century Companies Inc. | 0.01% | Reduce -39.1% | 687,427 | $27.3M |
| Franklin Resources Inc. | 0.01% | Reduce -71.1% | 684,482 | $27.2M |
| Baker Bros. Advisors LP | 0.15% | No change | 670,751 | $26.6M |
| Eventide Asset Management, LLC | 0.44% | New | 668,142 | $26.5M |
| Toronto Dominion Bank | 0.05% | New | 654,850 | $26.0M |
| TIG Advisors, LLC | 1.23% | New | 648,326 | $25.8M |
| D. E. Shaw & Co. | 0.02% | Reduce -22.6% | 643,808 | $25.6M |
| Bain Capital Life Sciences Investors, LLC | 2.28% | New | 635,000 | $25.2M |
| Qube Research & Technologies Ltd | 0.04% | Add +65.8% | 628,049 | $24.9M |
| BlackRock, Inc. | 0.00% | Add +5.5% | 625,420 | $24.8M |
| Citadel Advisors | 0.02% | Add +15.1% | 598,197 | $23.8M |
| 5AM Venture Management, LLC | 6.41% | No change | 580,945 | $23.1M |
| PFM Health Sciences, LP | 2.25% | Reduce -10.7% | 528,224 | $21.0M |
| Weiss Asset Management LP | 0.52% | New | 510,407 | $20.3M |
| Spruce Street Capital LP | 4.68% | Add +528.0% | 489,849 | $19.5M |
| Silverarc Capital Management, LLC | 2.18% | Add +1.8% | 466,345 | $18.5M |
| Trexquant Investment LP | 0.11% | Add +166.8% | 390,951 | $15.5M |
| UBS Group AG | 0.00% | Reduce -33.0% | 359,939 | $14.3M |
| Rock Springs Capital Management LP | 0.82% | Add +8.6% | 351,828 | $14.0M |
| JPMorgan Chase & Co. | 0.00% | Add +486.1% | 477,597 | $13.2M |
| Glazer Capital, LLC | 0.29% | New | 325,001 | $12.9M |
| Alyeska Investment Group, L.P. | 0.04% | New | 320,430 | $12.7M |
| Point72 Asset Management | 0.02% | New | 307,355 | $12.2M |
| Royce & Associates LP | 0.11% | Reduce -23.4% | 278,064 | $11.0M |
| Caption Management, LLC | 0.54% | New | 274,116 | $10.9M |
| Nantahala Capital Management, LLC | 0.63% | No change | 254,803 | $10.1M |
| TD Asset Management Inc | 0.01% | Reduce -35.7% | 242,044 | $9.6M |
| HighMark Wealth Management LLC | 3.83% | No change | 236,785 | $9.4M |
| Eagle Health Investments LP | 1.79% | Add +107.8% | 214,291 | $8.5M |
| SummitTX Capital, L.P. | 0.26% | Reduce -37.8% | 206,847 | $8.2M |
| Deutsche Bank AG | 0.00% | Add +21.6% | 189,961 | $7.5M |
| Renaissance Technologies | 0.01% | Reduce -33.8% | 185,000 | $7.3M |
| Schonfeld Strategic Advisors LLC | 0.06% | New | 171,933 | $6.8M |
| T. Rowe Price Investment Management, Inc. | 0.00% | Add +10968.8% | 170,016 | $6.8M |
| Marshall Wace, LLP | 0.01% | Reduce -22.2% | 168,177 | $6.7M |
| Fred Alger Management, LLC | 0.03% | Add +3.7% | 168,170 | $6.7M |
| Holocene Advisors, LP | 0.02% | Add +58.4% | 160,942 | $6.4M |
| Atom Investors LP | 0.45% | Add +764.0% | 158,509 | $6.3M |
| Burkehill Global Management, LP | 0.31% | No change | 150,000 | $6.0M |
| Platinum Investment Management Ltd. | 1.38% | Reduce -11.2% | 137,741 | $5.5M |
| LMR Partners LLP | 0.06% | New | 125,000 | $5.0M |
| HRT Financial LP | 0.01% | Add +961.6% | 116,992 | $4.6M |
| Voloridge Investment Management, LLC | 0.02% | Reduce -67.8% | 111,956 | $4.4M |
| Freestone Grove Partners LP | 0.03% | New | 109,327 | $4.3M |
| Legal & General Group Plc | 0.00% | Add +4.5% | 110,207 | $4.3M |
| Geode Capital Management, LLC | 0.00% | Add +23.0% | 107,778 | $4.3M |
| AQR Arbitrage LLC | 0.08% | New | 98,028 | $3.9M |
| Y-Intercept (Hong Kong) Ltd | 0.07% | Add +742.3% | 96,367 | $3.8M |
| Caitong International Asset Management Co., Ltd | 0.69% | Add +2811.3% | 93,685 | $3.7M |
| Harvest Management LLC | 1.69% | New | 80,000 | $3.2M |
| Citigroup Inc. | 0.00% | Add +2660.2% | 74,276 | $3.0M |
| Jain Global LLC | 0.04% | Reduce -92.2% | 71,513 | $2.8M |
| Virtu Financial LLC | 0.11% | New | 67,775 | $2.7M |
| Pictet Asset Management Holding SA | 0.00% | New | 96,910 | $2.7M |
| Two Sigma Investments, LP | 0.00% | Add +4.2% | 59,844 | $2.4M |
| Squarepoint Ops LLC | 0.00% | Reduce -38.1% | 50,606 | $2.0M |
| Water Island Capital LLC | 0.23% | New | 41,000 | $1.6M |
| Jane Street Group, LLC | 0.00% | Reduce -91.5% | 40,968 | $1.6M |
| Boothbay Fund Management, LLC | 0.04% | Add +22.0% | 39,656 | $1.6M |
| Knott David M Jr | 0.92% | Add +875.0% | 39,000 | $1.5M |
| Russell Investments Group, Ltd. | 0.00% | Reduce -48.1% | 38,812 | $1.5M |
| ADAR1 Capital Management, LLC | 0.09% | No change | 38,566 | $1.5M |
| Candriam S.C.A. | 0.01% | Reduce -90.8% | 36,254 | $1.4M |
| Buckland Partners Management Co LLC | 0.72% | New | 30,000 | $1.2M |
| Voya Investment Management LLC | 0.00% | No change | 29,670 | $1.2M |
| Cinctive Capital Management LP | 0.07% | Reduce -65.2% | 25,350 | $1.0M |
"% of holder's portfolio" is CNTA's weight in each manager's 13F, not the share of Centessa Pharmaceuticals Ltd. the manager owns.